Wikipedia
Macrogen, Inc. is a South Korean public biotechnology company. The company's headquarters are located in Seoul. The company was founded in 1997 by Jun-Seong Seo, a professor at Seoul National University. It was venture capital-backed until its initial public offering (IPO) and subsequent listing on the KOSDAQ market in 2000, making it the first Korean biotechnology firm to raise funds through an IPO. The company announced plans in 2010 to map the "Korean genome" based on the notion that United States-backed genome mapping efforts up to that time were representative of the " Caucasian genome" rather than the " Human genome" as claimed. By 2015, the company was described by one news outlet as "a global leader in personalized genomic medicine".